/
/
/

Glaxosmithkline Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,938.90
Volume (₹)36,151.00
High (₹)2,972.80
Upper Circuit3,525.00
Low (₹)2,925.50
Lower Circuit2,350.00
Prev Close2,937.50
52W High (₹)3,120.70
Price2,949.40
52W Low (₹)2,088.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)49726.60 Cr
Div. Yield (%)1.94
PE Ratio46.55
Debt to Equity0.00
Price to Book16.94
Book Value134.77
EPS (TTM)63.05
Face Value10.00
ROE (%)48.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
GLAXONSE
LTP
1W Low
1W High
Market cap (₹)
1900.8-19.2 (-1.00%)
1896.80
1984.80
4,56,833Cr
9146.5-92.5 (-1.00%)
9087
9467
2,45,426Cr
4829.5-220.5 (-4.37%)
4823
5066
1,87,320Cr
1129.4-61.6 (-5.17%)
1125.10
1187
1,13,217Cr
1380.7-42.8 (-3.01%)
1376
1426.10
1,12,212Cr
1846.4-92.1 (-4.75%)
1811.70
1949
1,01,155Cr
2109.6-61.9 (-2.85%)
2107.20
2192
97,626Cr
2329.8-53.1 (-2.23%)
2327.30
2419.20
96,859Cr
1157.5-20.5 (-1.74%)
1154.40
1179.90
96,406Cr
1653.7+8.4 (0.51%)
1622.60
1717
93,614Cr
2949.4-157 (-5.05%)
2908.50
3120
49,727Cr

Key Highlights of Glaxosmithkline Pharmaceuticals Ltd Balance Sheet

Glaxosmithkline Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹169.41Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹169.41Cr, and the reserves and surplus of the company is ₹2087.47Cr.

The company has its non-current liabilities with total liabilities of ₹4141.3Cr as of 2026-03-31.

The current liabilities are ₹1757.11Cr as of 2026-03-31. At the same time, current assets are ₹3543.12Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹25.36Cr and tangible assets of ₹280.07Cr, provided in the Glaxosmithkline Pharmaceuticals Ltd financial statements.